Eczema: Symptoms, Causes, Types, and Treatment Guide

What Is Eczema?

Eczema is a group of chronic inflammatory skin conditions that cause dry, itchy, and inflamed skin. The term serves as an umbrella covering several distinct subtypes, but when most people say "eczema," they mean atopic dermatitis, the most common and most studied form.^[1] Eczema is not contagious. You cannot catch it from another person or spread it through touch.

At its core, eczema involves a breakdown in the skin's protective barrier. Healthy skin locks in moisture and keeps irritants out. In eczema, that barrier is compromised, so water escapes, allergens and microbes slip in, and the immune system overreacts with inflammation.^[2] The result is the hallmark itch-scratch cycle: intense itching leads to scratching, which damages the skin further, which triggers more inflammation and more itching.

Eczema rarely exists in isolation. It belongs to a cluster of related allergic conditions known as the atopic triad: eczema, asthma, and allergic rhinitis (hay fever). These conditions share overlapping genetic and immune pathways, and having one raises your risk for the others. Collectively, allergic diseases affect roughly 30% of the global population and touch nearly 80% of households.

Eczema vs. Atopic Dermatitis: Understanding the Terms

You will see "eczema" and "atopic dermatitis" used interchangeably in many sources. Technically, eczema is the broader category, and atopic dermatitis is one specific type within it. Think of it like "headache" versus "migraine." All migraines are headaches, but not all headaches are migraines.

In clinical practice, atopic dermatitis accounts for the vast majority of eczema cases. It is the form most heavily researched, and most treatment guidelines focus on it specifically.^[3] Throughout this guide, we use "eczema" when discussing the condition broadly and "atopic dermatitis" or "AD" when referencing specific research findings. For a side-by-side look at how eczema differs from similar conditions, see our comparison of psoriasis and eczema.

How Common Is Eczema?

Eczema is one of the most common skin conditions on the planet. The numbers are striking.

A 2023 analysis of the Global Burden of Disease data found that atopic dermatitis affected approximately 171 million people worldwide in 2019, with an age-standardized prevalence of 2,277 per 100,000 population. That represents a 28.6% increase from 133 million cases in 1990.

Children bear the heaviest burden. In resource-rich countries, the pooled 12-month prevalence of AD reaches 16.3% in children aged 0 to 5 years.^[1] Among adults, it sits at approximately 9.3%.^[1] Prevalence peaks between ages 5 and 9, then gradually declines, though many people carry the condition well into adulthood.

The economic toll is equally significant. Atopic dermatitis generates 7.48 million disability-adjusted life years (DALYs) globally, reflecting both direct healthcare costs and indirect costs from lost work, school absences, and reduced productivity.

The practical takeaway: eczema is not a minor nuisance. It is a major global health condition affecting hundreds of millions of people, with a measurable impact on daily life, work, and well-being. If your eczema limits what you can do, you may have legal protections. Learn more about how severe eczema affects daily functioning and legal rights.

What Causes Eczema?

No single factor causes eczema. The condition emerges from a complex interplay of genetics, immune dysfunction, skin barrier defects, microbiome imbalance, and environmental exposures.^[2] These five root causes do not act alone. They feed into each other, so a barrier crack invites bacteria, bacteria trigger inflammation, and inflammation weakens the barrier further.

Understanding these causes helps explain why eczema behaves differently in different people, and why a treatment that works for one person may fail for another. For a deeper exploration, visit our article on the root causes of atopic dermatitis.

Genetics and Immune Factors

Genetics play a dominant role. Twin studies show that identical twins are roughly three times more concordant for atopic dermatitis than fraternal twins, with overall heritability estimated at approximately 75%.^[2] In practical terms: if one identical twin has eczema, the other develops it far more often than chance would predict (concordance rates range from 0.15 to 0.86).^[2]

The strongest known genetic risk factor is a mutation in the filaggrin (FLG) gene, a structural protein essential for building a strong skin barrier. Up to 50% of all patients with atopic dermatitis carry FLG loss-of-function mutations, and two common variants affect around 9% of the European population.^[2]

On the immune side, eczema involves a T cell imbalance. During acute flares, Th2 cytokines (IL-4, IL-13, IL-5, IL-31) dominate, driving inflammation and elevated IgE levels.^[4] As the condition becomes chronic, Th1 and Th17 responses layer on top, which is why long-standing eczema often feels different (thicker, more stubborn) than a fresh flare.^[5] Shared genetic risk variants for asthma, hay fever, and eczema operate largely by modulating gene expression in these same immune cells, particularly helper T cells and regulatory T cells.^[6]

For more on the genetic dimension, explore our guide to eczema and genetics.

The Skin Barrier and Microbiome

Even in skin that looks normal, people with eczema show measurable barrier dysfunction. If you have ever noticed that your "clear" skin still feels tight and dry, this is why. Filaggrin mutations leave the skin fissured at a microscopic level, allowing allergens and irritants to slip through.^[2] That penetration triggers immune activation, which further damages the barrier, locking in a vicious cycle.

The skin microbiome adds another layer. Healthy skin hosts a diverse community of bacteria that help maintain barrier integrity and regulate immune responses.^[39] For a broader look at how the microbiome shapes skin health, see our guide on what the microbiome is and why it matters. In eczema, that diversity collapses. Staphylococcus aureus is found on 70%–90% of actively inflamed eczema skin in children with AD, compared to much lower rates on healthy skin, with the degree of dysbiosis correlating with disease severity.^[39] This bacterial overgrowth worsens inflammation and increases infection risk.

Environmental factors, from pollution to climate to personal care products, can tip the balance in genetically predisposed individuals. The rapidly increasing global prevalence of eczema cannot be explained by genetics alone, pointing to a major role for environmental exposures.^[28]

Recognizing Eczema Symptoms

Because eczema stems from barrier and immune problems that vary from person to person, the symptoms it produces vary just as widely. A small dry patch on your wrist is eczema. So is the raw, weeping skin that keeps you awake at 2 a.m. Recognizing the full spectrum helps you seek the right care at the right time.

The Hallmark Symptoms

Itch is the defining feature. Not mild, background-noise itch, but the kind that makes you dig your nails into your skin before you are fully awake. In clinical studies of moderate-to-severe AD, 100% of patients reported pruritus at baseline, with 75% scoring 7 or higher on a 10-point severity scale.^[7]

Clinicians sometimes call eczema "the itch that rashes." The itch arrives first. Scratching follows, and only then does the visible rash appear. Beyond itch, you may experience:

• Dryness and scaling: Skin feels rough, tight, and flaky
• Redness and inflammation: Patches of irritated, swollen skin
• Cracking and fissuring: Painful splits, especially on hands and fingers
• Weeping and crusting: Fluid-filled blisters that ooze and form crusts in acute flares
• Lichenification: Thickened, leathery skin from chronic scratching

Sleep disruption is nearly universal. Picture lying in bed, exhausted, while your skin burns and your hands move to scratch before you can stop them. Among adults with moderate-to-severe AD, 43% scored 7 or higher on a sleep disturbance scale, and only 6.4% reported no sleep loss at all.^[7] Itch and sleep disturbance correlate directly (r = 0.61), confirming what patients already know: nighttime scratching and poor rest feed each other.^[7]

Eczema on Different Skin Tones

Eczema does not always look "red." On darker skin tones, it often appears as brown, purple, or ashen gray patches rather than the classic pink-red presentation described in most textbooks.^[8] This mismatch between textbook images and real-world skin leads to underdiagnosis and delayed treatment in people with skin of color. If your skin feels intensely itchy and dry but does not match the "red rash" photos you see online, you may still have eczema.

Mild, Moderate, and Severe Eczema

Clinicians classify eczema severity using validated tools like SCORAD and EASI, which assess the extent and intensity of skin involvement.^[9] These tools correlate strongly with each other (Pearson's r = 0.65) but only moderately with patient-reported quality of life, especially at higher severity levels.^[9] This gap highlights an important truth: how eczema looks on the surface does not always match how it feels.

In children, about 1 in 4 with AD experience moderate-to-severe fatigue, and 42% report more than four nights of broken sleep per week. What drives that exhaustion? Not disease severity alone, but the sleep disturbance itself and the daytime impairment it leaves behind.

Knowing your severity level matters because it determines which treatments are appropriate. But the numbers only tell part of the story. The next section explores the different types of eczema, each with its own patterns and challenges.

Types of Eczema

Knowing your symptoms and triggers matters, but so does knowing which kind of eczema you are dealing with. Eczema is not one disease. It is a family of related conditions that share the hallmarks of itch, inflammation, and barrier dysfunction yet differ in their triggers, distribution, and appearance. Dermatologists recognize seven major types, and identifying yours is the first step toward targeted treatment.

For a detailed breakdown of each, visit our guide to different types of eczema.

The Seven Major Types at a Glance

Having atopic dermatitis also raises your risk for other eczema types. Individuals with AD face a 2.44-fold increased risk of developing irritant contact dermatitis, likely because their already-compromised barrier lets irritants slip through more easily.^[11]

Hand dermatitis shows how messy these categories get in real life. In one hospital cohort, 39.4% of hand eczema cases were irritant contact dermatitis, 46.8% were allergic contact dermatitis, and 3.4% were dyshidrotic eczema.^[12] Many patients had more than one type at the same time, which is why a dermatologist's eye matters more than a label.

For deeper dives into specific types, explore our guides on dyshidrotic eczema and nummular eczema.

Eczema Triggers and Flare-Ups

Understanding what eczema is and which type you have sets the stage, but day-to-day management hinges on a different question: what sets off your flares? Causes and triggers are not the same thing. Causes are the underlying factors (genetics, immune dysfunction) that make you susceptible. Triggers are the external or internal events that ignite a flare in someone who already carries that susceptibility. Identifying your personal triggers is one of the most powerful steps you can take toward fewer flares.

Common Trigger Categories

Research identifies several major trigger categories, though their relative importance shifts with age. In one clinical study, the most common triggers in children were heat (43.2%), airborne allergens (28.4%), and skin irritants (22.6%).^[17] For adults, the ranking looked different: skin irritants topped the list (58.9%), followed by heat (47.7%) and psychological stress (34.6%).^[17]

• Environmental irritants: Soaps, detergents, fragrances, rough fabrics
• Allergens: Dust mites, pollen, pet dander, mold^[17]
• Climate and weather: Heat, humidity, dry cold air, sweating^[17]
• Psychological stress: Emotional stress modulates immune function and worsens flares^[18]
• Infections: Bacterial, viral, and fungal skin infections
• Hormonal changes: Puberty, menstruation, pregnancy, menopause^[19]
• Dietary factors: Food allergens in some individuals, particularly young children^[20]

Climate plays a particularly strong role. Think of that prickling heat you feel the moment you step outside in July: in one study, 54.8% of children and 58.9% of adults with AD flared during the warm season.^[17] Sweat ranked among the most frequently reported triggers in both age groups.^[17]

Maternal stress during pregnancy may even program eczema risk in the next generation. Five of six observational studies found significant associations between maternal stress and childhood AD development, possibly by reshaping the fetal immune system before birth.^[18] Hormonal shifts more broadly (puberty, menstruation, pregnancy, menopause) can also reshape flare patterns. See our guide on how hormones cause eczema.

Why Triggers Vary from Person to Person

Your trigger profile is as unique as your fingerprint. Two people with identical eczema severity may flare from completely different exposures, one from wool sweaters, another from emotional stress before a deadline. This variation stems from differences in genetics, barrier function, immune sensitivity, and microbiome composition. A simple flare diary (date, possible trigger, severity) can help you spot your personal patterns over time.

For a science-backed breakdown of the most common triggers, see our guides on 7 eczema triggers backed by science and the stress-eczema connection.

Eczema Treatment: An Overview

Once you know your triggers, the next question is what to do when a flare arrives anyway. Eczema treatment follows a stepwise approach: you start with the foundations and escalate only as needed. The goal is not a cure (there is no cure yet) but sustained control, meaning fewer flares, less itch, better sleep, and improved quality of life.^[3]

Most people with mild to moderate eczema achieve good control with emollients, topical anti-inflammatory preparations, and trigger avoidance.^[3] For those with moderate-to-severe disease, newer therapies have transformed the treatment landscape. For a complete treatment deep dive, visit our guide to atopic dermatitis treatments.

Foundational Skin Care

Regardless of severity, every eczema treatment plan starts with the same foundation: regular use of emollients and gentle bathing practices.^[3] Emollients restore moisture, reinforce the skin barrier, and reduce the frequency of flares. They are not optional extras; they are the base layer upon which all other treatments build. For guidance on applying moisturizers in the right order, see our guide on how to layer moisturizers for thirsty skin.

Patient and family education also forms part of this foundation. When you understand the condition, know how to apply treatments correctly, and can spot early flare signs, outcomes improve.^[3] Written action plans, recommended by national guidelines, give you a clear record of what to do and when.^[21]

Medical Therapies by Severity

A network meta-analysis of 97 trials (24,679 patients) confirmed that multiple systemic treatments now offer meaningful relief for moderate-to-severe AD.^[22] Lebrikizumab showed comparable efficacy to dupilumab, while high-dose upadacitinib demonstrated the numerically highest relative efficacy among the agents studied.^[22] For patients who have cycled through cream after cream without lasting improvement, these newer options represent a genuine shift in what is possible.

A shared patient-clinician approach improves compliance, satisfaction, and outcomes.^[3] The most effective treatment plan is the one you will actually follow.

Emerging and OTC Options

Beyond prescription therapies, over-the-counter options play an important role for mild-to-moderate eczema and for daily maintenance between flares. Formulations that support the skin microbiome while calming low-grade inflammation are gaining attention, and for good reason: they fit into a morning routine as easily as sunscreen. Products like an effective eczema cream that combine anti-inflammatory ingredients with prebiotic support offer an accessible starting point.

For help choosing the right product, see our guide on what cream is good for eczema or visit SmartLotion to explore the full product line.

Eczema by Body Location

Treatment choices depend not only on severity but also on where eczema appears. The skin on your eyelid is paper-thin; the skin on your palm is several times thicker. That difference means a steroid safe for your arm could damage your face. Location shapes both how eczema looks and how it should be managed.

Why Location Matters

Eyelid skin measures less than 1 mm thick, while palm skin can be several times that.^[23] Clinicians factor in these differences when choosing treatment potency for each body site.

Distribution patterns also shift with age. Childhood-onset AD tends to favor flexural sites (inner elbows, behind the knees), while adult-onset AD more often settles on the hands, head, and neck.^[24]

Common Affected Areas

• Face and eyelids: Thin, sensitive skin requires gentle, low-potency treatments. See our facial eczema treatment guide
• Hands: Frequent washing and occupational exposure make hand eczema persistent. Explore our hand eczema guide
• Scalp: Overlaps with seborrheic dermatitis; requires specialized approaches^[25]
• Flexural areas: Inner elbows, behind knees, wrists, ankles; classic childhood AD distribution^[24]
• Lower legs: May involve stasis dermatitis in older adults with venous insufficiency^[15]

Each location presents unique challenges: the constant hand-washing that comes with parenting or healthcare work, the visible patches on your face that make you self-conscious in meetings, the scalp itch that wakes you at 3 a.m. Understanding your specific pattern helps you and your clinician build a targeted plan.

Eczema Across Age Groups and Life Stages

Because eczema favors different body sites at different ages, the condition is not static. It evolves as you grow, shifting in location, severity, and daily impact. Understanding these patterns helps you anticipate what comes next and adjust your approach before a new phase catches you off guard.

Infants and Children

Eczema is primarily an early childhood disease. In a large real-world study, 60.4% of newly diagnosed pediatric patients were under 3 years old at diagnosis.^[26] Parents often notice it first as rough, red patches on a baby's cheeks or scalp, sometimes spreading to the outer arms and legs. As children grow, the pattern migrates to flexural areas: the inner elbows, the backs of the knees, the creases where sweat collects.^[24]

Children diagnosed before age 3 rapidly acquire atopic comorbidities. Within one year of AD diagnosis, asthma prevalence in this group jumped from 10.6% to 19.1%, and food allergy prevalence rose from 4.9% to 8.9%.^[26] For a complete guide to managing infant eczema, see our baby eczema guide. Parents can also review Dr. Harlan's infant eczema treatment protocol for practical application guidance.

Teens and Adults

Persistence into adolescence is common, and the stakes shift. The lifetime prevalence of AD in adolescents aged 12 to 17 years is 14.8%.^[27] At an age when fitting in feels like survival, visible eczema can fuel low self-esteem, mood disturbances, poor sleep, and school absenteeism.^[27]

At least 1 in 4 cases of AD are adult-onset, challenging the old assumption that eczema is purely a childhood disease.^[28] Adult-onset AD often presents differently, with more localized involvement of the hands, head, and neck.^[24] Eczema prevalence also shows a sex-related shift: higher in males before puberty, then higher in females during and after puberty.

For age-specific guidance, explore our resources on eczema in teens.

The Atopic March

The atopic march describes a common progression: eczema appears first in infancy, then food allergy, asthma, and allergic rhinitis follow in later childhood. Diet and nutrition also play a role in this progression (see our evidence-based guide on diet and eczema). By 10 years after an AD diagnosis, roughly 50% of children develop at least one additional atopic condition, mainly asthma or allergic rhinitis.^[26]

However, the march is not always a neat single-file line. Children diagnosed with AD after age 3 often already carry a high atopic comorbidity burden at the time of their eczema diagnosis, with approximately 40% having at least one comorbidity within one year.^[26] In other words, atopic diseases can develop in parallel rather than in sequence.

Living with Eczema

Eczema does not stay on your skin. It follows you to bed at night, into the office the next morning, and through every social interaction where you wonder if someone is staring. Understanding the full scope of its impact is the first step toward building a life that is not defined by your skin.

The Emotional and Social Burden

Over half of adult patients report that eczema has a moderate to extremely large effect on their quality of life.^[10] The standard measurement tool, the Dermatology Life Quality Index (DLQI), defines scores of 11 to 20 as a "large effect" on daily life.^[10] What does that look like in practice? Canceling plans because your skin is flaring. Choosing clothes to hide your arms. Dreading handshakes.

The mental health toll runs deep. Over 10% of people with moderate-to-severe AD demonstrate depressive symptoms, and among those with severe disease, 88% feel their ability to tackle life is at least partly compromised.^[10] That might look like dreading Monday morning not because of work itself, but because your hands are cracked and visible. Depression and anxiety disorders occur more often in patients with severe atopic dermatitis, and psychological stress worsens the condition in return, locking in a feedback loop that is hard to break alone.^[29]

Sleep disruption affects up to 60% of children with eczema, increasing to 83% during flares.^[30] Even during clinical remission, individuals with eczema demonstrate more sleep disturbance than healthy individuals.^[30] The ripple effects extend to family members who are awakened by a child's scratching and restlessness.^[30]

The economic burden compounds the emotional one. Fifty-seven percent of adults with AD miss at least one day of work per year because of their condition.^[10] For parents, the hidden costs add up too: extra laundry loads, nightly moisturizing routines, and time away from work for dermatology appointments.^[10]

For strategies to protect your confidence and emotional well-being, see our guide on feeling confident with eczema.

Daily Management Foundations

Living well with eczema requires a consistent daily routine built on three pillars: skin care, trigger avoidance, and stress management. A gentle cleansing and moisturizing routine, morning and night, forms the backbone. Think of it as brushing your teeth: not exciting, but skipping it has consequences. Identifying and minimizing your personal triggers reduces flare frequency, while managing stress (through exercise, mindfulness, or professional support) addresses one of the most common adult triggers.^[17]

Many people find that SmartLotion, which combines anti-inflammatory, prebiotic, and moisturizing action in one formulation, fits naturally into their daily routine as a standalone treatment for mild-to-moderate flares. For practical daily management tips, explore our guide on how to tackle eczema safely and our advice on sleeping with eczema.

How Eczema Is Diagnosed

Managing eczema well requires knowing you actually have it. There is no single blood test or biopsy that definitively diagnoses eczema. Instead, diagnosis relies on clinical evaluation: a thorough patient history, physical examination, and established diagnostic criteria. Getting the right diagnosis matters because several other conditions look similar but require entirely different treatment.

Clinical Criteria

The most widely used framework is the Hanifin and Rajka criteria, established in 1980. A diagnosis requires three or more major features (itch, typical rash pattern and location, chronic or relapsing course, personal or family history of atopy) plus three or more minor features.^[31]

When researchers compared self-reported eczema to physician-confirmed diagnoses, self-reports were highly specific (0.95 to 0.96) but only moderately sensitive (0.70).^[31] In plain terms: if you think you have eczema, you are probably right. But a professional evaluation catches cases that self-assessment misses.

Administrative coding alone is unreliable. In one validation study, only 29.9% of patients coded with the standard billing code for atopic dermatitis actually met clinical diagnostic criteria on examination.^[32] The takeaway? A proper in-person assessment matters far more than what appears in a medical record.

Conditions That Mimic Eczema

Several conditions look enough like eczema to fool even clinicians. In one study, 22.7% to 38.1% of patients initially coded as having atopic dermatitis turned out to have something else entirely.^[32]

Patch testing may be warranted when allergic contact dermatitis is suspected, particularly if eczema is localized to specific areas or does not respond to standard treatment.^[36] For a detailed comparison, see our guide on the difference between psoriasis and eczema.

When to See a Dermatologist

A correct diagnosis is only the starting point. Many people manage mild eczema successfully on their own with moisturizers and gentle skin care, but there are clear signals that it is time to seek professional help. Waiting too long can allow infections to take hold and quality of life to slide unnecessarily.

Signs You Need Professional Help

What to Expect at Your Visit

A dermatology visit for eczema typically includes a detailed history (when symptoms started, what makes them better or worse, family history of atopy), a full skin examination, and severity scoring. Bring photos of your worst flares; they capture what your skin may not show on appointment day. You can also review Dr. Harlan's atopic dermatitis treatment protocol for adults to understand what a structured care plan looks like in practice. Your dermatologist may recommend patch testing if contact allergy is suspected, or allergy testing if food or environmental allergens seem involved.

The most valuable outcome is a personalized treatment plan built around your life, not just your skin. When you and your clinician discuss your goals, concerns about side effects, and realistic ability to follow the regimen, compliance and outcomes both improve.^[3] If your eczema is severe or complex, your dermatologist may refer you to an allergist or immunologist for further evaluation.

Frequently Asked Questions About Eczema

Is eczema contagious?

No. Eczema is not contagious. You cannot catch it from touching someone who has it, sharing towels, or any other form of contact. Eczema results from a combination of genetic susceptibility, immune dysfunction, and environmental triggers.^[2] Learn more in our article on whether eczema can spread.

Can eczema be cured?

There is currently no cure for eczema. However, the condition can be effectively managed. Many children outgrow their eczema, and adults can achieve long periods of remission with the right treatment plan.^[3] The goal of treatment is sustained control, not cure: fewer flares, less itch, and better quality of life.

What is the root cause of eczema?

Eczema has no single root cause. It arises from the interplay of five factors: genetic predisposition (especially filaggrin gene mutations), immune system dysregulation (Th2-dominant inflammation), skin barrier dysfunction, microbiome imbalance, and environmental triggers.^[2][5] Genetics account for approximately 75% of the risk, but environmental factors explain the rapid rise in prevalence over recent decades.^[2]

What is the best treatment for eczema?

The best treatment depends on your severity level. For mild eczema, regular moisturizing and low-potency topical corticosteroids during flares are often sufficient.^[3] For moderate-to-severe cases, options include calcineurin inhibitors, phototherapy, biologics like dupilumab, and oral JAK inhibitors. A personalized, stepwise approach guided by a dermatologist produces the best outcomes. See our full eczema treatment guide.

Can you prevent eczema?

You cannot fully prevent eczema, especially if you carry genetic risk factors. However, early and consistent use of emollients in high-risk infants has been studied as a potential strategy to reduce the likelihood of developing AD, though evidence remains inconclusive.^[37] Avoiding known triggers, maintaining skin hydration, and managing stress can help prevent flares in people who already have the condition.

Is eczema an autoimmune disease?

Eczema is not classified as a classic autoimmune disease. In autoimmune conditions, the immune system attacks the body's own healthy tissue. In eczema, the immune system overreacts to external triggers (allergens, irritants, microbes) rather than targeting self-tissue.^[6] However, eczema does involve significant immune dysregulation, and research continues to explore the overlap between atopic and autoimmune pathways.^[38] For a deeper look at this question, see our guide on whether atopic dermatitis is an autoimmune disorder.

References

1. Volke A, Toompere K, Laisaar K-T, et al. "12-month prevalence of atopic dermatitis in resource-rich countries: a systematic review and meta-analysis." Sci Rep. 2022;12:15125. doi:10.1038/s41598-022-19508-7
2. Elmose C, Thomsen SF. "Twin Studies of Atopic Dermatitis: Interpretations and Applications in the Filaggrin Era." J Allergy (Cairo). 2015;2015:902359. doi:10.1155/2015/902359
3. Lugović-Mihić L, Barac E, Tomašević R, Parać E, Zanze L, Ljevar A, Dolački L, Štrajtenberger M. "Atopic Dermatitis-Related Problems in Daily Life, Goals of Therapy and Deciding Factors for Systemic Therapy: A Review." Pharmaceuticals (Basel). 2024;17(11):1455. doi:10.3390/ph17111455
4. Tsoi LC, Rodriguez E, Degenhardt F, Baurecht H, Wehkamp U, Volks N, Szymczak S, Swindell WR, Sarkar MK, Raja K, Shao S, Patrick M, Gao Y, Uppala R, Perez White BE, Getsios S, Harms PW, Maverakis E, Elder JT, Franke A, Gudjonsson JE, Weidinger S. "Atopic Dermatitis Is an IL-13–Dominant Disease with Greater Molecular Heterogeneity Compared to Psoriasis." Journal of Investigative Dermatology. 2019. View Study
5. Tsoi LC, Rodriguez E, Stölzl D, Wehkamp U, Sun J, Gerdes S, et al. "Progression of acute-to-chronic atopic dermatitis is associated with quantitative rather than qualitative changes in cytokine responses." J Allergy Clin Immunol. 2020;145(5):1406–1415. View Study
6. Ferreira MA, Vonk JM, Baurecht H, et al. "Shared genetic origin of asthma, hay fever and eczema elucidates allergic disease biology." Nat Genet. 2017;49(12):1752–1757. doi:10.1038/ng.3985
7. Gooderham M, Guttman-Yassky E, Igawa K, Kabashima K, Esfandiari E, Rylands AJ, Williams A, Nixon A, Dent JE, Simpson E. "Rocatinlimab Improves Patient-Reported Outcomes in Adults with Moderate-to-Severe Atopic Dermatitis: Results from a Double-Blind Placebo-Controlled Phase 2b Study." Dermatology and Therapy. 2024;14:3351–3366. doi:10.1007/s13555-024-01303-z
8. Nguyen C, Thompson J, Nguyen DA, Wong CM, Scheufele CJ, Carletti M, Weis SE. "Presentations of Cutaneous Disease in Various Skin Pigmentations: Chronic Atopic Dermatitis." HCA Healthcare Journal of Medicine. 2024. View Study
9. Sanclemente G, Hernández N, Tamayo L, Chaparro D, López A, Colombian Atopic Dermatitis Research Group. "Correlation between disease severity indices and quality of life measurement tools in atopic dermatitis patients." Biomédica. 2024;44:318–327. doi:10.7705/biomedica.6998
10. Ali F, Vyas J, Finlay AY. "Counting the Burden: Atopic Dermatitis and Health-related Quality of Life." Acta Dermato-Venereologica. 2020;100(12):adv00161. doi:10.2340/00015555-3511
11. Schütte MG, Tamminga SJ, de Groene GJ, Kezic S, van der Molen HF. "Work-related and personal risk factors for occupational contact dermatitis: A systematic review of the literature with meta-analysis." Contact Dermatitis. 2023;88(3):171–187. doi:10.1111/cod.14253
12. Mense SA, Maher S, Chovatiya R. "A Practical Approach to Chronic Hand Eczema." Dermatology and Therapy. 2025. View Study
13. Tavecchio S, Angileri L, Pozzo Giuffrida F, Germiniasi F, Marzano AV, Ferrucci S. "Efficacy of Dupilumab on Different Phenotypes of Atopic Dermatitis: One-Year Experience of 221 Patients." Journal of Clinical Medicine. 2020. View Study
14. Borda LJ, Wikramanayake TC. "Seborrheic Dermatitis and Dandruff: A Comprehensive Review." Journal of Clinical and Investigative Dermatology. 2015. View Study
15. Yosipovitch G, Nedorost ST, Silverberg JI, Friedman AJ, Canosa JM, Cha A. "Stasis Dermatitis: An Overview of Its Clinical Presentation, Pathogenesis, and Management." American Journal of Clinical Dermatology. 2023. View Study
16. Emmanuel OM, Karovska AV, Ikedilo O. "Scabies-induced lichen simplex chronicus misdiagnosed as psychogenic pruritus: a case report." Journal of Medical Case Reports. 2021. View Study
17. Dégboé et al. "Comorbidities and Environmental Factors Associated with Atopic Dermatitis in Children and Adults in Dermatology-Venereology in Cotonou, Benin." Dermatology Research and Practice. 2021;2021:1502721. doi:10.1155/2021/1502721
18. Kantor R, Silverberg JI. "Environmental risk factors and their role in the management of atopic dermatitis." Expert Review of Clinical Immunology. 2017;13(1):15–26. doi:10.1080/1744666X.2016.1212660
19. Weare-Regales N, Chiarella SE, Cardet JC, Prakash YS, Lockey RF. "Hormonal Effects on Asthma, Rhinitis, and Eczema." J Allergy Clin Immunol Pract. 2022. View Study
20. Trikamjee T, Comberiati P, D'Auria E, Peroni D, Zuccotti GV. "Nutritional Factors in the Prevention of Atopic Dermatitis in Children." Frontiers in Pediatrics. 2021. View Study
21. Thandi CS, Constantinou S, Vincent R, Ridd MJ. "Where and how have written action plans for atopic eczema/dermatitis been developed and evaluated? Systematic review." Skin Health and Disease. 2023;3(3):e213. View Study
22. Silverberg JI, Bieber T, Paller AS, Beck L, Kamata M, Puig L, Wiseman M, Ezzedine K, Irvine AD, Foley P, Del Rosso J, Stein Gold L, Johansson E, Dossenbach M, Gallo G, Akmaz B, Casillas M, Karlsson A, Curteis T, Chovatiya R. "Lebrikizumab vs Other Systemic Monotherapies for Moderate-to-Severe Atopic Dermatitis: Network Meta-analysis of Efficacy." Dermatology and Therapy. 2025. View Study
23. Wang Y, Tian M, Guo R, Du F, Qiu L, Tang Y. "Quantification of normal skin thickness using very high-frequency ultrasound: a clinical study in Chinese adults." Quantitative Imaging in Medicine and Surgery. 2025. View Study
24. Silverberg JI, Boguniewicz M, Hanifin J, et al. "Dupilumab Treatment in Adults with Moderate-to-Severe Atopic Dermatitis is Efficacious Regardless of Age of Disease Onset: a Post Hoc Analysis of Two Phase 3 Clinical Trials." Dermatology and Therapy. 2022;12(11):2595–2613. doi:10.1007/s13555-022-00822-x
25. Leroy AK, Cortez de Almeida RF, Obadia DL, Frattini S, Melo DF. "Scalp Seborrheic Dermatitis: What We Know So Far." Skin Appendage Disorders. 2023. View Study
26. Leshem YA, Weil C, Busse WW, Beck LA, Chodick G, Cyr SL, Bosman K, Lubwama R. "Real-World Onset of Atopic Comorbidities Relative to Atopic Dermatitis in Pediatric Patients." Dermatology and Therapy. 2025;15:3425–3436. View Study
27. Paller AS, Ladizinski B, Mendes-Bastos P, et al. "Efficacy and Safety of Upadacitinib Treatment in Adolescents With Moderate-to-Severe Atopic Dermatitis: Analysis of the Measure Up 1, Measure Up 2, and AD Up Randomized Clinical Trials." JAMA Dermatology. 2023;159(5):526–535. View Study
28. Grafanaki K, Bania A, Kaliatsi EG, Vryzaki E, Vasilopoulos Y, Georgiou S. "The Imprint of Exposome on the Development of Atopic Dermatitis across the Lifespan: A Narrative Review." J Clin Med. 2023;12(6):2180. View Study
29. Liang S, Huang K-Y, Zhang L, et al. "Acupuncture for atopic dermatitis: a systematic review and meta-analysis." BMJ Open. 2024;14(12):e084788. doi:10.1136/bmjopen-2024-084788
30. Eichenfield LF, Tom WL, Chamlin SL, et al. "Guidelines of Care for the Management of Atopic Dermatitis Part 1: Diagnosis and Assessment of Atopic Dermatitis." Journal of the American Academy of Dermatology. 2014;70(2):338–351. doi:10.1016/j.jaad.2013.10.010
31. Silverberg JI, Patel N, Immaneni S, et al. "Assessment of atopic dermatitis using self-report and caregiver report: a multicentre validation study." Br J Dermatol. 2015;173(6):1400–1404. doi:10.1111/bjd.14031
32. Hsu DY, Dalal P, Sable KA, Voruganti N, Nardone B, West DP, Silverberg JI. "Validation of international classification of disease ninth revision codes for atopic dermatitis." Allergy. 2017;72(7):1091–1095. doi:10.1111/all.13113
33. Jain R, Sangoi R, Pascal S, Sharma Y, Takodara YV, Singh AA, Shah Y, Prashanth A, Agrawal M, Wankhede P. "Insights Into the Epidemiological, Clinical, Histopathological, and Dermoscopic Aspects of Chronic Plaque Psoriasis." Cureus. 2024. View Study
34. Chanyachailert P, Leeyaphan C, Bunyaratavej S. "Cutaneous Fungal Infections Caused by Dermatophytes and Non-Dermatophytes: An Updated Comprehensive Review of Epidemiology, Clinical Presentations, and Diagnostic Testing." Journal of Fungi. 2023. View Study
35. Paray AA, Chandra M, Wani I, Singh M, Kaur A, Najar IA, Paray NA, Dar MM. "Scabies as a Neglected Tropical Disease: A Comprehensive Review of Pathogenesis, Epidemiology, Clinical Manifestations, Diagnosis and Treatment." Yale Journal of Biology and Medicine. 2025. View Study
36. Houle MC, Holness DL, DeKoven J. "Occupational Contact Dermatitis: An Individualized Approach to the Worker with Dermatitis." Current Dermatology Reports. 2021. View Study
37. Simpson EL, Michaels LC, Ramsey K, et al. "Emollients to Prevent Pediatric Eczema: A Pragmatic and Decentralized Randomized Clinical Trial." JAMA Dermatology. 2025. View Study
38. D'Auria E, Minutoli M, Colombo A, Sartorio MUA, Zunica F, Zuccotti G, Lougaris V. "Allergy and autoimmunity in children: non-mutually exclusive diseases. A narrative review." Frontiers in Pediatrics. 2023. View Study
39. Edslev SM, Agner T, Andersen PS. "Skin Microbiome in Atopic Dermatitis." Acta Dermato-Venereologica. 2020. View Study